Results 211 to 220 of about 272,695 (294)

Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome in patients with high-risk smoldering multiple myeloma included in the GEM-CESAR trial. [PDF]

open access: yesHaematologica
Puig N   +36 more
europepmc   +1 more source

[Lessons learned from the evaluation of the Third Addiction Prevention Plan of Navarre]. [PDF]

open access: yesAn Sist Sanit Navar
Baigorria Feltrin FN   +3 more
europepmc   +1 more source

LocoMMotion: a study of real-life current standards of care in triple-class exposed patients with relapsed/refractory multiple myeloma - 2-year follow-up (final analysis). [PDF]

open access: yesLeukemia
Mateos MV   +22 more
europepmc   +1 more source

Presentación

open access: yesArbor: Ciencia, Pensamiento y Cultura, 2012
Manuel Cuenca Cabeza
doaj  

Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance. [PDF]

open access: yesJ Clin Oncol
Mateos MV   +30 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy